Testosterone levels and clinical features of schizophrenia with emphasis on negative symptoms and aggression

References

• Abel KM, Drake R, Goldstein JM. Sex differences in schizophrenia. Int Rev Psychiatry 2010;22:417–28.
   PubMed Web of Science ®Google Scholar
• Purves-Tyson T, Handelsman D, Double K, Owens S, Bustamante S, Weickert C. Testosterone regulation of sex steroid-related mRNAs and dopamine-related mRNAs in adolescent male rat substantia nigra. BMC Neurosci 2012;13:95.
   PubMed Web of Science ®Google Scholar
• Kaneda Y, Fujii A. Effects of chronic neuroleptic administration on the hypothalamo pituitary–gonadal axis of male schizophrenics. Prog Neuro-Psychopharmacol Biol Psychiatry 2000; 24:251–8.
   PubMed Web of Science ®Google Scholar
• Ko YH, Lew YM, Jung SW, Joe SH, Lee CH, Jung HG, et al. Short-term testosterone augmentation in male schizophrenics: A randomized, double-blind, placebo-controlled trial. J Clin Psychopharmacol 2008;28:375–83.
   PubMed Web of Science ®Google Scholar
• Andersen NC. Negative symptoms in schizophrenia:definition and reliability. Arch Gen Psychiatry 1982;39:784–8.
   PubMed Web of Science ®Google Scholar
• Akhondzadeh S, Rezaei F, Larijani B, Nejatisafa AA, Kashani L, Abbasi SH. Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia. Schizophr Res 2006;84:405–10.
   PubMed Web of Science ®Google Scholar
• Shirayama Y, Hashimoto K, Suzuki Y, Higuchi T. Correlation of plasma neurosteroid levels to the severity of negative symptoms in male patients with schizophrenia. Schizophr Res 2002;1;58:69–74.
   PubMed Web of Science ®Google Scholar
• Ko YH, Jung SW, Joe SH, Lee CH, Jung HG, Jung IK. et al. Association between serum testosterone levels and the severity of negative symptoms in male patients with chronic schizophrenia. Psychoneuroendocrinology 2007;32, 385–91.
   PubMed Web of Science ®Google Scholar
• Prosser ES, Csernansky JG, Kaplan J, Thiemann S, Becker TJ, Hollister LE. Depression, Parkinsonian symptoms and negative symptoms in schizophrenics treated with neuroleptics. J. Nerv. Ment. Dis 1987;175, 100–5.
   PubMed Web of Science ®Google Scholar
• Moore L, Kyaw M, Vercammen A, Lenroot R, Kulkarni J, Curtis J et al. Serum testosterone levels are related to cognitive function in men with schizophrenia. Psychoneuroendocrinology 2013:38:1717–28. S0306–4530(13)00045–0.
   PubMed Web of Science ®Google Scholar
• Goyal RO, Sagar R, Ammini AC, Khurana ML, Alias AG. Negative correlation between negative symptoms of schizophrenia and testosterone levels. Ann NY Acad Sci 2004;1032:291–4.
   PubMed Web of Science ®Google Scholar
• Strous RD, Rachel Maayan R, Lapidus R, Stryjer R, Lustig M, Kotler M. et al. Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia. Arch Gen Psychiatry 2003;60:133–41.
   PubMed Web of Science ®Google Scholar
• Elias A, Kumar A. Testosterone for schizophrenia. Cochrane Database Syst Rev 2007;(3):CD006197
   Google Scholar
• Eisenegger C, Haushofer J, Fehr E. The role of testosterone in social interaction. Trends Cogn Sci 2011;15:263–71.
   PubMed Web of Science ®Google Scholar
• Rasanen P, Hakko H, Visuri S, Paanila J, Kapanen P, Suomela T. Serum testosterone levels, mental disorders and criminal behaviour. Acta Psychiat Scand 1999; 99:348–52.
   PubMed Web of Science ®Google Scholar
• Yolken R. ELISA: Enzyme-linked immunosorbent assay. Hosp Pract 1978;13:121–7.
   PubMed Web of Science ®Google Scholar
• Fischbach F. A manual of laboratory and diagnostic tests. Chemistry studies, 7th edition. Philadelphia, PA: Lippincott Williams & Wilkins; 2004.
   Google Scholar
• Smith S, Wheeler M, Murray R, O’Keane V. The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic–pituitary–gonadal axis J Clin Psychopharmacol 2002;22:109–14.
   PubMed Web of Science ®Google Scholar
• Simpson G, Mahmoud R, Lasser R, Kujawa M, Bossier C, Turkoz I. A 1-year double-blind study of 2 doses of long-acting risperidone in stable patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry 2006;67:1194–203.
   PubMed Web of Science ®Google Scholar
• Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261–76.
   PubMed Web of Science ®Google Scholar
• Yudofsky SC, Silver JM, Jackson W, Endicott J, Williams D. The Overt Aggression Scale for the objective rating of verbal and physical aggression. Am J Psychiatry 1986;143:35–9.
   PubMed Web of Science ®Google Scholar
• Posner K, Melvin G, Stanley B, Oquendo MA, Gould M. Factors in the assessment of suicidality in youth. CNS Spectr 2007;12:156–6.
   PubMed Web of Science ®Google Scholar
• Robert D. Serum gonadal steroid hormones in young schizophrenic patients. Psychoneuroendo crinology 1994;19:373–85.
   PubMed Web of Science ®Google Scholar
• Mason NJ. Serum testosterone differences between patients with schizophrenia and those with affective disorder. Biol Psychiatry 1988;23:357–66.
   PubMed Web of Science ®Google Scholar
• Bradley AJ, Dinan TG. A systematic review of hypothalamic– pituitary–adrenal axis function in schizophrenia: Implications for mortality. J Psychopharmacol 2010;24:91–118.
   PubMed Web of Science ®Google Scholar
• Goldstein JM. Sex, hormones and affective arousal circuitry dysfunction in schizophrenia. Hormones Behav 2006;50:612–22.
   PubMed Web of Science ®Google Scholar
• Kritzer MF. Long-term gonadectomy affects the density of tyrosine hydroxylase- but not dopamine-beta-hydroxylase-, choline acetyltransferase- or serotonin-immunoreactive axons in the medial prefrontal cortices of adultmale rats. Cereb Cortex 2003;13:282–96.
   PubMed Web of Science ®Google Scholar
• Johnson ML, Day A, Ho CC, David Walker Q, Francis R, Kuhn CM. Androgen decreases dopamine neurone survival in rat midbrain. J Neuroendocrinol 2010;22:238–47.
   PubMed Web of Science ®Google Scholar
• Alias A. Schizotypy and leadership: A contrasting model for deficit symptoms, and a possible therapeutic role for sex hormones. Med Hypoth 2000;54:537–52.
   PubMed Web of Science ®Google Scholar
• Mazur A, Booth A. Testosterone and dominance in men. Behav Brain Sci 1998;21:353–97.
   PubMed Web of Science ®Google Scholar
• Ceskova E, Prikryl R, Kaspárek T. Testosterone in first-episode schizophrenia. Neuro Endocrinol Lett 2007;28:811–4.
   PubMed Web of Science ®Google Scholar
• de Souza Silva MA, Mattern C, Topic B, Buddenberg TE, Huston JP. Dopaminergic and serotonergic activity in neostriatum and nucleus accumbens enhanced by intranasal administration of testosterone. Eur Neuropsychopharmacol 2009;19:53–63. doi: 10.1016/j.euroneuro.2008.08.003. Epub 2008 Sep 24.
   PubMed Web of Science ®Google Scholar
• Ritsner MS, Gibel A, Shleifer T, Boguslavsky I, Zayed A, Maayan R, et al. Pregnenolone and dehydroepiandrosterone as an adjunctive treatment in schizophrenia and schizoaffective disorder: An 8-week, double-blind, randomized, controlled, 2-center, parallel-group trial. J Clin Psychiatry 2010;71:1351–62. doi:10.4088/JCP.09m05031yel. Epub 2010 Jun 15.
   PubMed Web of Science ®Google Scholar
• Bergman N, Parzer P, Kaiser D, Maier-Braunleder S, Mundt C, Klier C. Testosterone and gonadotropins but not estrogen associated with spatial ability in women suffering from schizophrenia: A double-blind, placebo-controlled study. Psychoneuroendocrinology 2008;33:507–16.
   PubMed Web of Science ®Google Scholar
• Kulkarni J, de Castella A, Headey B, Marston N, Sinclair K, Lee S, et al. Estrogens and men with schizophrenia: Is there a case for adjunctive therapy? Schizophr Res 2011;125:278–83. doi: 10.1016/j.schres.2010.10.009. Epub 2010 Nov 9.
   PubMed Web of Science ®Google Scholar
• Weickert CS, Miranda-Angulo AL, Wong J, Perlman WR, Ward SE, Radhakrishna V, et al. Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia. Hum Mol Genet 2008;1;17:2293–309. doi:10.1093/hmg/ddn130.
   Web of Science ®Google Scholar
• Kaneda Y. Possible relationship between testosterone and comorbid major depressive episode in male patients with schizophrenia treated with typical antipsychotic medications. Clin Neuropharmacol 2003;26:291–3.
   PubMed Web of Science ®Google Scholar
• Kaneda Y, Kawamura I, Ohmori T, Fujii A. Impact of switch from typical to atypical antipsychotic drugs on quality of life and gonadal hormones in male patients with schizophrenia. Neuroendocrin Lett 2004;25:135–40.
   PubMed Web of Science ®Google Scholar
• Mäkinen J, Miettunen J, Isohanni M, Koponen H. Negative symptoms in schizophrenia—A review2008;62;5:334–41. doi:10.1080/08039480801959307
   Google Scholar
• Prikryl R, Ceskova E, Tronerova S, Kasparek T, Kucerova HP, Ustohal L, et al. Dynamics of neurological soft signs and its relationship to clinical course in patients with first-episode schizophrenia. Psychiatry Res 2012;30;200:67–72. doi: 10.1016/j.psychres.2012.03.008. Epub 2012 Apr 10.
   Web of Science ®Google Scholar
• Nolan KA, Volavka J, Czobor P, Sheitman B, Lindenmayer JP, Citrome LL, et al. Aggression and psychopathology in treatment-resistant inpatients with schizophrenia and schizoaffective disorder. J Psychiatr Res 2005;39:109–15.
   PubMed Web of Science ®Google Scholar
• Hodgins S. Violent behaviour among people with schizophrenia: A framework for investigations of causes, and effective treatment, and prevention Philos Trans R Soc Lond B Biol Sci 2008; 363:2505–18. doi:10.1098/rstb.2008.0034
   PubMed Web of Science ®Google Scholar
• Trainor BC, Sisk C, Nelson RJ. Hormones and the development and expression of aggressive behavio. In: Pfaff D, editor. Hormones, brain and behavior, 2nd edition. Amsterdam: Academic Press; 2009.
   Google Scholar
• Banks T, Dabbs J. Salivary testosterone and cortisol in deliquent and violent urban subculture. J Soc Psychol 1996;136:49–56.
   PubMed Web of Science ®Google Scholar
• Lester D. Suicide as an aggressive act. J Gen Psychol 1968;79:83–6.
   PubMed Web of Science ®Google Scholar
• Horesh N, Gothelf D, Ofek H, Weizman T, Apter A. Impulsivity as a correlate of suicidal behaviour in adolescent psychiatric inpatients. Crisis 1999;20:8–14.
   PubMedGoogle Scholar
• Roggenbach J, Müller-Oerlinghausen B, Franke L. Suicidality, impulsivity and aggression—Is there a link to 5HIAA concentration in the cerebrospinal fluid? Psychiatry Res 2002;113:193–206.
   PubMed Web of Science ®Google Scholar
• Birger M, Swartz M, Cohen D, Alesh Y, Grishpan C, Kotelr M. Aggression: The testosterone–serotonin link. IMAJ 2003;5:653–58.
   Web of Science ®Google Scholar
• Tripodianakis J, Rouvali O, Istikoglou C. Gonadal axis hormones in psychiatric male patients after a suicidal attempt. Eur Arch Psychiatry Clin Neurosci 2007;257:35–9.
   Web of Science ®Google Scholar
• Brown A, Hembree W, Friedman J, Kaufmann C, Gorman J. The gonadal axis in men with schizophrenia. Psychiatry Res 1995;57:231–9.
   PubMed Web of Science ®Google Scholar
• Brambilla F, Guerrini A, Guastalla A, Rovere C, Riggi F. Neuroendocrine effects of haloperidol therapy in chronic schizophrenia. Psychopharmacologia 1975;14;44:17–22.
   Google Scholar
• Markianos M, Hatzimanolis J, Lykouras L. Switch from neuroleptics to clozapine does not influence pituitary–gonadal axis hormone levels in male schizophrenic patients. Eur Neuropsychopharmacol 1999;9:533–6.
   PubMed Web of Science ®Google Scholar